Rexulti Full Prescribing Information, Dosage & Side Effects

Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning

Investigation Questions Drug's Approval for Agitation in AD

REXULTI® (brexpiprazole), MDD

REXULTI- brexpiprazole tablet

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

FDA-Approved Drugs to Treat Schizophrenia Journal of Psychosocial Nursing and Mental Health Services

Rexulti: Package Insert

Video: Using the REXULTI Savings Card

Rexulti Lawsuit - Uncontrollable Gambling Addition on The Rise

Rexulti: Package Insert

REXULTI® (brexpiprazole), MDD

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease

REXULTI® (brexpiprazole), MDD

Rexulti: Package Insert

Rexulti tablet 3mg